Table 1.
Demographic data
| Mean ± SD or n | Range or % | |
|---|---|---|
| Case | 18 | |
| Eyes | 29 | |
| Age (years) | 57.7 ± 8.0 | 40–69 |
| Sex | ||
| Male | 7 | 39% |
| Female | 11 | 61% |
| Number of glaucoma medications (bottle) | ||
| 1 | 6 | |
| 2 | 6 | |
| 3 | 6 | |
| 2.0 ± 0.8 | 1–3 | |
| Glaucoma medication | ||
| Prostaglandin | 18 | 62% |
| β blocker | 16 | 55% |
| CAI | 10 | 34% |
| α2 stimulator | 7 | 24% |
| Pilocarpine | 1 | 3% |
| Best-corrected visual acuity (logMAR) | –0.03 | –0.08– –0.2 |
| Sperical equivalent refractive error (D) | –5.7 | –12.8– –1.3 |
| Visual field MD (dB) | –5.1 | –13.6– +0.2 |
| Lens status | ||
| Phakic | 22 | 76% |
| Pseudophakic | 7 | 24% |
| Corneal thickness (um) | 540 | 496–572 |
n, number; CAI, carbonic anhydrase inhibitor; logMAR, logarithm of the minimum angle of resolution; MD, mean deviation; dB, decibels; D, diopters.